EMR showing upside potential
Emerson is half way into the cycle with price target ranging from $93 to $96. I expect earnings to be good, but the recent indication for a hostile acquisition might overshadow the ER. I believe this will trend in a range until mid March when this could start its next leg up.
Disclaimer: My opinion on stocks are mine alone and not to be taken as Investment advice.
Disclaimer: My opinion on stocks are mine alone and not to be taken as Investment advice.
免责声明
这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。